Principal Financial Group Inc. Has $28.82 Million Stock Holdings in LifeStance Health Group, Inc. (NASDAQ:LFST)

Principal Financial Group Inc. raised its position in LifeStance Health Group, Inc. (NASDAQ:LFST - Free Report) by 6.1% during the third quarter, according to its most recent 13F filing with the SEC. The fund owned 4,116,766 shares of the company's stock after buying an additional 235,316 shares during the period. Principal Financial Group Inc. owned about 1.08% of LifeStance Health Group worth $28,817,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. CIBC Asset Management Inc bought a new stake in shares of LifeStance Health Group during the second quarter worth approximately $53,000. Algert Global LLC acquired a new stake in LifeStance Health Group during the 2nd quarter worth $57,000. Victory Capital Management Inc. raised its position in shares of LifeStance Health Group by 27.0% during the 2nd quarter. Victory Capital Management Inc. now owns 14,407 shares of the company's stock valued at $71,000 after acquiring an additional 3,063 shares during the last quarter. Park Edge Advisors LLC acquired a new position in shares of LifeStance Health Group in the 3rd quarter valued at $73,000. Finally, Townsquare Capital LLC acquired a new position in shares of LifeStance Health Group in the 3rd quarter valued at $73,000. 85.50% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

LFST has been the subject of a number of analyst reports. Barclays boosted their price objective on shares of LifeStance Health Group from $6.00 to $7.00 and gave the company an "underweight" rating in a report on Monday, November 11th. The Goldman Sachs Group upgraded shares of LifeStance Health Group from a "neutral" rating to a "buy" rating and set a $10.00 price objective for the company in a research report on Monday, December 16th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and three have assigned a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of "Hold" and a consensus price target of $8.70.

Insiders Place Their Bets

In other LifeStance Health Group news, Director Robert Bessler sold 75,000 shares of the stock in a transaction that occurred on Wednesday, November 27th. The shares were sold at an average price of $7.54, for a total transaction of $565,500.00. Following the transaction, the director now owns 1,424,447 shares in the company, valued at $10,740,330.38. This represents a 5.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Company insiders own 6.60% of the company's stock.

LifeStance Health Group Stock Performance

Shares of LifeStance Health Group stock traded up $0.03 during trading on Wednesday, hitting $7.29. 377,670 shares of the stock were exchanged, compared to its average volume of 1,525,461. The company has a current ratio of 1.32, a quick ratio of 1.32 and a debt-to-equity ratio of 0.19. The company has a fifty day moving average price of $7.22 and a 200-day moving average price of $6.42. The stock has a market capitalization of $2.79 billion, a price-to-earnings ratio of -28.04 and a beta of 1.28. LifeStance Health Group, Inc. has a 1-year low of $4.64 and a 1-year high of $9.20.

LifeStance Health Group (NASDAQ:LFST - Get Free Report) last issued its earnings results on Thursday, November 7th. The company reported ($0.02) EPS for the quarter, topping the consensus estimate of ($0.07) by $0.05. LifeStance Health Group had a negative return on equity of 6.66% and a negative net margin of 7.90%. The company had revenue of $312.70 million during the quarter, compared to the consensus estimate of $302.25 million. During the same period in the previous year, the company posted ($0.17) EPS. The firm's revenue for the quarter was up 18.9% compared to the same quarter last year. As a group, equities analysts predict that LifeStance Health Group, Inc. will post -0.2 EPS for the current fiscal year.

LifeStance Health Group Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.